SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001095811-00-002701
Filing Date
2000-08-14
Accepted
2000-08-14 00:00:00
Documents
4
Period of Report
2000-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR QUARTER ENDED JUNE 30, 2000 e10-q.txt 10-Q 71008
2 EXHIBIT 3.1 ex3-1.txt EX-3.1 6642
3 EXHIBIT 3.2 ex3-2.txt EX-3.2 87401
4 FINANCIAL DATA SCHEDULE ex27-1.txt EX-27.1 2283
  Complete submission text file 0001095811-00-002701.txt   169240
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22570 | Film No.: 695619
SIC: 2833 Medicinal Chemicals & Botanical Products